Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
about
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes MellitusLiver function tests and risk prediction of incident type 2 diabetes: evaluation in two independent cohorts.Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study.Renal function interferes with copeptin in prediction of major adverse cardiac events in patients undergoing vascular surgery.Copeptin, Insulin Resistance, and Risk of Incident Diabetes in Older Men.Diabetes Complications in Childhood Diabetes-New Biomarkers and Technologies.Genetic vasopressin 1b receptor variance in overweight and diabetes mellitusPlasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the Community.Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantationPlasma copeptin levels are inversely associated with intima-media-thickness in men: the population-based KORA F4 study.Vasopressin: a novel target for the prevention and retardation of kidney disease?Copeptin in obese children and adolescents: relationships to body mass index, cortisol and gender.Vasopressin and metabolic disorders: translation from experimental models to clinical use.Increased levels of copeptin before clinical diagnosis of preelcampsia.Effects of hydration on plasma copeptin, glycemia and gluco-regulatory hormones: a water intervention in humans.Effect of increased water intake on plasma copeptin in healthy adults.Plasma copeptin as marker of cardiovascular disease in asymptomatic type 2 diabetes patients.Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33).Identification of patients at risk for preeclampsia with the use of uterine artery Doppler velocimetry and copeptin.Plasma copeptin is associated with type 2 diabetes in men but not in women in the population-based KORA F4 studyPlasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes
P2860
Q28395801-A58D862D-CD4A-4CB7-90C7-61AD48717A09Q34531926-8172F40D-2D98-40CA-A870-897AC06E2AEFQ35136767-9BF601BD-4E96-4D8B-9B1C-2076063C00E7Q35392693-2E5B3281-82F1-4E35-8698-24A1528A98A4Q36060397-587C654F-D22F-473D-B0E4-91F102A8729DQ36095944-068C0E38-6656-42D8-BB98-D580A5DAE2CCQ36300778-6BD96D07-0152-40D6-838B-1F356CB1E4E1Q36965316-93C9E07E-0627-4924-9DC4-4B08DFAD7338Q37280819-BAEFDDD2-35E6-4276-AA29-30C39FCDAA86Q37306950-DB9410A6-C5A1-42F1-8B13-C4F46C116D45Q38084471-F5F384ED-F921-4D34-8F80-CC7B4C3298F4Q39394021-3CB3FD73-B1FC-4BE5-8364-F60E0A2173A6Q39422254-0B41C0F7-10FB-49BD-8911-B4A941EF609EQ45002550-F0D62862-1633-4097-9B51-DD58692B3D41Q47676004-30BDC291-E799-4FFD-8396-490E581946E0Q47742757-13DC3405-69EA-4B2A-B2A9-F6C37F3AF64FQ50648308-414AFBA1-3A96-4093-AC44-342DCC875DD0Q51035312-DA1A42A2-D3DE-4918-A2A1-0D2DEA96808CQ53749818-7C0FE03E-A0B0-43F0-BB3F-4661761671D8Q57052265-AFA7A734-E6CD-4EFD-B4A4-B941F7692673Q58803910-30B65899-AF7D-4B3E-88AE-525241BE1BE5
P2860
Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Sex differences in the associa ...... stage Disease (PREVEND) study.
@en
Sex differences in the associa ...... and Vascular Endstage Disease
@nl
type
label
Sex differences in the associa ...... stage Disease (PREVEND) study.
@en
Sex differences in the associa ...... and Vascular Endstage Disease
@nl
prefLabel
Sex differences in the associa ...... stage Disease (PREVEND) study.
@en
Sex differences in the associa ...... and Vascular Endstage Disease
@nl
P2093
P2860
P50
P1433
P1476
Sex differences in the associa ...... dstage Disease (PREVEND) study
@en
P2093
H L Hillege
R O B Gans
R T Gansevoort
S J L Bakker
P2860
P2888
P304
P356
10.1007/S00125-012-2545-X
P577
2012-04-15T00:00:00Z